MyHealthChecked PLC Statement re. COVID-19 testing (2130M)
17 Septiembre 2021 - 11:50AM
UK Regulatory
TIDMMHC
RNS Number : 2130M
MyHealthChecked PLC
17 September 2021
MyHealthChecked plc
( " MyHealthChecked " or " the Company " )
Statement re. COVID-19 testing
MyHealthChecked Plc (AIM: MHC), the consumer home-testing
healthcare company, notes the recent Government statement regarding
measures to simplify international travel.
As announced in the 7 July Trading update H1 revenues
dramatically increased to GBP3.27m (H1 2020: GBP12,700) driven by
COVID-19 testing services. This trend has continued into Q3 with
monthly testing volumes exceeding those seen in the final two
months of H1. Further information on Q3 trading will be provided in
the results statement scheduled for Wednesday 29 September
2021.
Whilst the Government has announced the removal of Day 2 testing
from an October date to be confirmed, the Directors remain
confident that monthly testing volumes will remain a significant
contributor to growth throughout the remainder of the financial
year, even with levels naturally lower than the peak levels seen
around summer holiday period. These revenues are still expected to
contribute significantly to the results for the financial year
ending 31 December 2021 and the Directors remain very optimistic
about the business prospects for the full year.
The requirements surrounding PCR testing for out-bound travel,
the "Fit to Fly" scheme, have not changed and Directors expect to
see these volumes continuing. The Directors also expect that these
newly announced changes to international travel will encourage more
people to travel abroad from the UK, and that this will contribute
to a rise in out-bound testing volumes.
As already stated, the Company's genomic testing service has
been focussed on its COVID-19 testing offering, however it provides
the foundation to create a wider portfolio of easy to use DNA tests
over the longer-term. MyHealthChecked plc has a strong pipeline of
genetic tests outside of COVID-19 to ensure long-term sustainable
revenue growth.
For further information contact:
MyHealthChecked plc www.myhealthchecked.com
P enny McCormick , Chief Executive via Walbrook PR
Officer
Gareth Davies, Chief Financial and
Operations Officer
SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)203 179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media & Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
IR)
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407
804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests, now in development following the acquisition of The
Genome Store in November 2020. The tests will be made available
online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
STRLRMFTMTIBBFB
(END) Dow Jones Newswires
September 17, 2021 12:50 ET (16:50 GMT)
Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024